{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:37Z","timestamp":1794047437240,"version":"4.8.0"},"reference-count":13,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"1","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2023.283237","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T09:53:19Z","timestamp":1684403599000},"page":"362-363","source":"Crossref","is-referenced-by-count":0,"title":["CD49d in chronic lymphocytic leukemia: a molecule with multiple regulation layers. Comment to \u201cSialylation regulates migration in chronic lymphocytic leukemia\u201d"],"prefix":"10.3324","volume":"109","author":[{"given":"Federico","family":"Pozzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Tissino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Zucchetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valter","family":"Gattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"56813","doi-asserted-by":"crossref","unstructured":"Natoni A, Cerreto M, De Propris MS. Sialylation regulates migration in chronic lymphocytic leukemia. Haematologica. 2023; 108(7):1851-1860.","DOI":"10.3324\/haematol.2022.281999"},{"key":"56814","doi-asserted-by":"crossref","unstructured":"Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, Bellis SL. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res. 2005; 65(11):4645-4652.","DOI":"10.1158\/0008-5472.CAN-04-3117"},{"key":"56815","doi-asserted-by":"crossref","unstructured":"Krysov S, Potter KN, Mockridge CI. Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo. Blood. 2010; 115(21):4198-4205.","DOI":"10.1182\/blood-2009-12-254847"},{"key":"56816","doi-asserted-by":"crossref","unstructured":"Natoni A, Farrell ML, Harris S. Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse model. Haematologica. 2020; 105(2):457-467.","DOI":"10.3324\/haematol.2018.212266"},{"key":"56817","doi-asserted-by":"crossref","unstructured":"Dal Bo M, Bulian P, Bomben R. CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia. Leukemia. 2016; 30(10):2011-2018.","DOI":"10.1038\/leu.2016.88"},{"key":"56818","doi-asserted-by":"crossref","unstructured":"Tissino E, Benedetti D, Herman SEM. Functional and clinical relevance of VLA-4 (CD49d\/CD29) in ibrutinib-treated chronic lymphocytic leukemia. J Exp Med. 2018; 215(2):681-697.","DOI":"10.1084\/jem.20171288"},{"key":"56819","doi-asserted-by":"crossref","unstructured":"Zucchetto A, Caldana C, Benedetti D. CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism. Blood. 2013; 122(19):3317-3321.","DOI":"10.1182\/blood-2013-06-507335"},{"key":"56820","doi-asserted-by":"crossref","unstructured":"Benedetti D, Tissino E, Pozzo F. NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-kappaB pathways. Leukemia. 2018; 32(3):654-662.","DOI":"10.1038\/leu.2017.296"},{"key":"56821","doi-asserted-by":"crossref","unstructured":"Malavasi F, Deaglio S, Damle R, Cutrona G, Ferrarini M, Chiorazzi N. CD38 and chronic lymphocytic leukemia: a decade later. Blood. 2011; 118(13):3470-3478.","DOI":"10.1182\/blood-2011-06-275610"},{"key":"56822","doi-asserted-by":"crossref","unstructured":"Zucchetto A, Vaisitti T, Benedetti D. The CD49d\/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells. Leukemia. 2012; 26(6):1301-1312.","DOI":"10.1038\/leu.2011.369"},{"key":"56823","doi-asserted-by":"crossref","unstructured":"Zucchetto A, Benedetti D, Tripodo C. CD38\/CD31, the CCL3 and CCL4 chemokines, and CD49d\/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Cancer Res. 2009; 69(9):4001-4009.","DOI":"10.1158\/0008-5472.CAN-08-4173"},{"key":"56824","doi-asserted-by":"crossref","unstructured":"Spaargaren M, Beuling EA, Rurup ML. The B cell antigen receptor controls integrin activity through Btk and PLCgamma2. J Exp Med. 2003; 198(10):1539-1550.","DOI":"10.1084\/jem.20011866"},{"key":"56825","doi-asserted-by":"crossref","unstructured":"Tissino E, Pozzo F, Benedetti D. CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression. Blood. 2020; 135(15):1244-1254.","DOI":"10.1182\/blood.2019003179"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283237\/75625","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283237\/76479","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11090\/75625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:04:05Z","timestamp":1794045845000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.283237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.283237","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,18]]}}}